Partnership Opportunities

For the first time ever we’re uniting senior ILD therapeutics decision-makers, from pioneering pharma and biotechs across the globe, at the inaugural Interstitial Lung Disease Drug Development Summit.

If you’re looking to exhibit your solutions and develop meaningful relationships with organizations prioritizing interstitial lung disease and antifibrotic drug development, then look no further. The digital ILD Summit is your all access pass to greater brand awareness, nurtured lead generation and networking of surgical precision with 50+ of the most engaged interstitial lung disease drug development experts in the world.

 

Position your company as leaders in the space by showcasing your message, your reputation and your solutions to the leading minds of drug developers focusing specifically on creating therapies to optimize anti-fibrotic effect for progressive fibrotic ILDS.

 

We know each business has unique needs and forging virtual connections is somewhat new, so we’ll work with you to build a bespoke package to satisfy your 2021 business objectives.

 

  • Secure a virtual exhibition booth to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies

 

  • Network one-to-one with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution

 

  • Deliver a presentation online and still be able to influence the thinking of translational and pre-clinical scientists working to identify new promising compounds

 

To maintain an industry-led focus we have strictly limited partnership opportunities available. Contact us today to learn how we can help you achieve your business goals faster and more effectively online at  sponsor@hansonwade.com

lung disease

In Association With